Mesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Peptides »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Peptide Library < Peptides < Peptides, Cyclic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000610 (2018) Indu Javeri [États-Unis] ; Kaliappanadar Nellaiappan [États-Unis] ; Charles Mcnemar [États-Unis] ; Kirill Yakovlevsky [États-Unis] ; Amina Soukrati [États-Unis] ; Phanindra Velisetty [États-Unis] ; Bijay Misra [États-Unis]Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.
000999 (2017) Yi-Ming Chen [Taïwan] ; Hsin-Hua Chen [Taïwan] ; Wen-Nan Huang [Taïwan] ; Tsai-Ling Liao [Taïwan] ; Jun-Peng Chen [Taïwan] ; Wen-Cheng Chao [Taïwan] ; Ching-Tsai Lin [Taïwan] ; Wei-Ting Hung [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Tsu-Yi Hsieh [Taïwan] ; Yi-Hsing Chen [Taïwan] ; Der-Yuan Chen [Taïwan]Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
000D54 (2016) Fei Li [République populaire de Chine] ; Zhenzhong Zhang [République populaire de Chine] ; Teng Cheng [République populaire de Chine] ; Rui Wei [République populaire de Chine] ; Yun Dai [République populaire de Chine] ; Mengqin Lv [République populaire de Chine] ; Danfeng Luo [République populaire de Chine] ; Xiaohua Zhu [République populaire de Chine] ; Ding Ma [République populaire de Chine] ; Ling Xi [République populaire de Chine] ; Qingjian Dong [République populaire de Chine] ; Xiangyi Ma [République populaire de Chine]SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL.
000D90 (2016) M. Philippart [Pays-Bas] ; J. Schmidt [Suisse] ; B. Bittner [Suisse]Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens.
001087 (2015) Renpeng Zhou [République populaire de Chine] ; Xiaoshan Wu [République populaire de Chine] ; Zhisen Wang [République populaire de Chine] ; Jinfang Ge [République populaire de Chine] ; Feihu Chen [République populaire de Chine]Interleukin-6 enhances acid-induced apoptosis via upregulating acid-sensing ion channel 1a expression and function in rat articular chondrocytes.
001174 (2015) Fabrizio De Benedetti [Italie] ; Hermine Brunner ; Nicolino Ruperto ; Rayfel Schneider ; Ricardo Xavier ; Roger Allen ; Diane E. Brown ; Jeffrey Chaitow ; Manuela Pardeo ; Graciela Espada ; Valeria Gerloni ; Barry L. Myones ; James W. Frane ; Jianmei Wang ; Terri H. Lipman ; Kamal N. Bharucha ; Alberto Martini ; Daniel LovellCatch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase III trial.
001765 (2012) Morten A. Karsdal [Danemark] ; Georg Schett ; Paul Emery ; Olivier Harari ; Inger Byrjalsen ; Andy Kenwright ; Anne C. Bay-Jensen ; Adam PlattIL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
001904 (2011) Jun Hashimoto [Japon] ; Patrick Garnero ; Désirée Van Der Heijde ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Hideki Yoshikawa ; Norihiro NishimotoHumanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study.
001A07 (2010) Patrick Garnero [France] ; Elizabeth Thompson ; Thasia Woodworth ; Josef S. SmolenRapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
001B41 (2008) Yasuo Adachi [Japon] ; Naoko Yoshio-Hoshino ; Norihiro NishimotoThe blockade of IL-6 signaling in rational drug design.
001D94 (????) Evangelos Terpos [Grèce] ; Kalliopi Fragiadaki ; Maria Konsta ; Cornelia Bratengeier ; Athanasios Papatheodorou ; Petros P. SfikakisEarly effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Peptides" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Peptides" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Peptides
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021